MCID: ARG006
MIFTS: 28

Aregenerative Anemia

Categories: Blood diseases, Rare diseases

Aliases & Classifications for Aregenerative Anemia

MalaCards integrated aliases for Aregenerative Anemia:

Name: Aregenerative Anemia 58 71
Refractory Anemias 71

Classifications:

Orphanet: 58  
Rare haematological diseases


Summaries for Aregenerative Anemia

MalaCards based summary : Aregenerative Anemia, also known as refractory anemias, is related to diamond-blackfan anemia 1 and diamond-blackfan anemia. An important gene associated with Aregenerative Anemia is TBXAS1 (Thromboxane A Synthase 1). The drugs Sargramostim and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, t cells and bone, and related phenotypes are pallor and bone marrow hypocellularity

Related Diseases for Aregenerative Anemia

Diseases related to Aregenerative Anemia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 10, show less)
# Related Disease Score Top Affiliating Genes
1 diamond-blackfan anemia 1 11.3
2 diamond-blackfan anemia 11.1
3 ghosal hematodiaphyseal dysplasia 11.1
4 deficiency anemia 10.4
5 thymoma, familial 10.4
6 thymoma 10.4
7 pancytopenia 10.0
8 glucosephosphate dehydrogenase deficiency 10.0
9 monocytic leukemia 10.0
10 refractory anemia 10.0

Graphical network of the top 20 diseases related to Aregenerative Anemia:



Diseases related to Aregenerative Anemia

Symptoms & Phenotypes for Aregenerative Anemia

Human phenotypes related to Aregenerative Anemia:

58 31 (showing 26, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 pallor 58 31 hallmark (90%) Very frequent (99-80%) HP:0000980
2 bone marrow hypocellularity 58 31 hallmark (90%) Very frequent (99-80%) HP:0005528
3 reticulocytopenia 58 31 hallmark (90%) Very frequent (99-80%) HP:0001896
4 fatigue 58 31 frequent (33%) Frequent (79-30%) HP:0012378
5 dyspnea 58 31 frequent (33%) Frequent (79-30%) HP:0002094
6 depressivity 58 31 occasional (7.5%) Occasional (29-5%) HP:0000716
7 fever 58 31 occasional (7.5%) Occasional (29-5%) HP:0001945
8 thrombocytopenia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001873
9 neutropenia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001875
10 bruising susceptibility 58 31 occasional (7.5%) Occasional (29-5%) HP:0000978
11 pancytopenia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001876
12 mood changes 58 31 occasional (7.5%) Occasional (29-5%) HP:0001575
13 fatigable weakness of skeletal muscles 58 31 occasional (7.5%) Occasional (29-5%) HP:0030197
14 erythroid hypoplasia 58 31 occasional (7.5%) Occasional (29-5%) HP:0012133
15 abnormality of interleukin secretion 58 31 occasional (7.5%) Occasional (29-5%) HP:0011117
16 decreased proportion of cd4-positive helper t cells 31 occasional (7.5%) HP:0005407
17 abnormal proportion of cd8-positive t cells 31 occasional (7.5%) HP:0031393
18 lymphadenopathy 58 31 very rare (1%) Very rare (<4-1%) HP:0002716
19 dementia 58 31 very rare (1%) Very rare (<4-1%) HP:0000726
20 cognitive impairment 58 Very rare (<4-1%)
21 abnormality of the cardiovascular system 58 Occasional (29-5%)
22 abnormality of immune system physiology 58 Occasional (29-5%)
23 abnormal bleeding 58 Occasional (29-5%)
24 abnormality of bone marrow cell morphology 58 Frequent (79-30%)
25 decreased proportion of cd4-positive t cells 58 Occasional (29-5%)
26 abnormal proportion of cd8 t cells 58 Occasional (29-5%)

Drugs & Therapeutics for Aregenerative Anemia

Drugs for Aregenerative Anemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 29, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sargramostim Approved, Investigational Phase 3 123774-72-1, 83869-56-1
2
Lenograstim Approved, Investigational Phase 3 135968-09-1
3
Cytarabine Approved, Investigational Phase 3 147-94-4 6253
4
Daunorubicin Approved Phase 3 20830-81-3 30323
5
Idarubicin Approved Phase 3 58957-92-9 42890
6 Molgramostim Investigational Phase 3 99283-10-0
7 Antineoplastic Agents, Immunological Phase 3
8 Antimetabolites Phase 3
9 Immunosuppressive Agents Phase 3
10 Adjuvants, Immunologic Phase 3
11 Immunologic Factors Phase 3
12 Anti-Infective Agents Phase 3
13 Antiviral Agents Phase 3
14 Gemtuzumab Phase 3
15 Antibiotics, Antitubercular Phase 3
16 Anti-Bacterial Agents Phase 3
17
Panitumumab Approved, Investigational Phase 1 339177-26-3 50070211
18
Oxaliplatin Approved, Investigational Phase 1 61825-94-3 5310940 9887054 6857599 43805
19
Decitabine Approved, Investigational Phase 1 2353-33-5 451668
20
Irinotecan Approved, Investigational Phase 1 97682-44-5, 100286-90-6 60838
21
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
22
Alvocidib Experimental, Investigational Phase 1 146426-40-6, 131740-09-5 5287969
23 Cola Phase 1
24 Immunoglobulins Phase 1
25 Mitogens Phase 1
26 Antibodies, Monoclonal Phase 1
27 Antibodies Phase 1
28 Histone Deacetylase Inhibitors Phase 1
29 Protein Kinase Inhibitors Phase 1

Interventional clinical trials:

(showing 6, show less)
# Name Status NCT ID Phase Drugs
1 A Randomized, Placebo-Controlled, Double Blind, Trial of the Administration of the MDR Modulator, Zosuquidar Trihydrochloride (LY335979), During Conventional Induction and Post-Remission Therapy in Patients Greater Than 60 Years of Age With Newly Diagnosed Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation or High-Risk Refractory Anemia With Excess Blasts Completed NCT00046930 Phase 3 cytarabine;daunorubicin hydrochloride;zosuquidar trihydrochloride;Placebo
2 Randomised Induction and Post Induction Therapy in Older Patients (≥61 Years of Age) With Acute Myeloid Leukemia (AML) and Refractory Anemia With Excess Blasts (RAEB, RAEB-t) Completed NCT00121303 Phase 3 cytarabine;daunorubicin hydrochloride;gemtuzumab ozogamicin
3 A Randomized Multicenter Study of More Intensive Versus Less Intensive Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia (AML) or Transformed Refractory Anemia With Excess Blasts (RAEB-t). Terminated NCT00363025 Phase 3 Idarubicin versus daunorubicin
4 Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated With Severe Neutropenia Refractory to Immunosuppressive Therapy Active, not recruiting NCT00604201 Phase 2
5 Targeted Demethylation to Enhance Response or Overcome Resistance to EGFR Blocking Agents in KRAS Wild-type Metastatic Colorectal Cancer Patients Using Sequential Decitabine and Panitumumab Completed NCT00879385 Phase 1 Dacogen™ (decitabine);Vectibix® (panitumumab)
6 Phase I Trial of Vorinostat (SAHA) in Combination With Alvocidib (Flavopiridol) in Patients With Relapsed, Refractory, or (Selected) Poor Prognosis Acute Leukemia or Refractory Anemia With Excess Blasts-2 Completed NCT00278330 Phase 1 alvocidib;vorinostat

Search NIH Clinical Center for Aregenerative Anemia

Genetic Tests for Aregenerative Anemia

Anatomical Context for Aregenerative Anemia

MalaCards organs/tissues related to Aregenerative Anemia:

40
Bone Marrow, T Cells, Bone, Thymus, Myeloid, Neutrophil

Publications for Aregenerative Anemia

Articles related to Aregenerative Anemia:

(showing 156, show less)
# Title Authors PMID Year
1
[Erythrophagocytosis by blast cells and de novo T cell LAL without cytogenetic abnormalities in a Moroccan patient]. 61
32963668 2020
2
Intrauterine Growth Retardation Complicated by Biermer's Disease: An Observation in Togo. 61
31198611 2019
3
TREATMENT STRATEGIES AND OUTCOME OF PARVOVIRUS B19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: A CASE SERIES AND LITERATURE REVIEW OF 128 PATIENTS. 61
31448778 2019
4
Citrobacter freundii infection in silver catfish (Rhamdia quelen): Hematological and histological alterations. 61
30266258 2018
5
Hospital-Based Case-Control Study of MDS Subtypes and Benzene Exposure in Shanghai. 61
28146040 2017
6
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes. 61
27562492 2016
7
Adult-onset Diamond-Blackfan anemia with a novel mutation in the exon 5 of RPL11: too late and too rare. 61
26185635 2015
8
Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions. 61
26124688 2015
9
Immune aregenerative anemia without erythroblastopenia: a previously undescribed condition. 61
23408098 2013
10
[Refractory anemias]. 61
24195247 2013
11
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts. 61
23065512 2013
12
[Detecting a peak in fraction beta by capillary electrophoresis: interference due to iomeprol]. 61
23587586 2013
13
How I treat transfusional iron overload. 61
22919029 2012
14
[Aregenerative anemia and erythrocytes hemighosts: a case report]. 61
21896417 2011
15
[Criteria for suspecting a myelodysplastic syndrome]. 61
21425539 2010
16
Genetic variants in the noncoding region of RPS19 gene in Diamond-Blackfan anemia: potential implications for phenotypic heterogeneity. 61
20054847 2010
17
[Neonatal Pearson syndrome. two case studies]. 61
19914050 2010
18
Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series. 61
20043618 2009
19
[Pernicious anemia in an adolescent with type 1 diabetes mellitus]. 61
19211232 2009
20
Early neurological impairment and severe anemia in a newborn with Pearson syndrome. 61
18553104 2009
21
Treatment of iron overload in thalassemia. 61
19337180 2008
22
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 61
18497321 2008
23
Treatment options in myelodysplastic syndromes: a new frontier. 61
18606581 2008
24
[Immune pathophysiology of refractory anemias]. 61
18326316 2008
25
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. 61
18037415 2007
26
Linezolid-related pancytopenia in organ-transplant patients: report of two cases. 61
17653505 2007
27
Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes. 61
17011983 2006
28
Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state. 61
16314788 2005
29
Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes. 61
16104874 2005
30
A comparative review of classification systems in myelodysplastic syndromes (MDS). 61
16085011 2005
31
[Extensive bone marrow necrosis as presenting manifestation of sickle cell disease in Africa]. 61
15460150 2004
32
Increased caspase-3 activity in refractory anemias: lack of evidence for Fas pathway implication. 61
12399987 2002
33
Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia. 61
12163050 2002
34
[Transient erythroblastopenia in the context of Epstein-Barr virus infection]. 61
12042121 2002
35
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. 61
11858190 2002
36
Lethal hydrops fetalis due to congenital dyserythropoietic anemia in a newborn: association of a new skeletal abnormality. 61
11764104 2001
37
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. 61
11493439 2001
38
Diamond-Blackfan anemia. 61
11176237 2001
39
[Collagen gastritis, an unusual cause of anemia in children. Report of 2 cases]. 61
11218583 2001
40
Secondary iron overload. 61
11722978 2001
41
Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry. 61
10654453 2000
42
Nutritional anemias. 61
10595751 1999
43
Rheumatoid arthritis associated with myelodysplastic syndrome: a case report. 61
10402176 1999
44
EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on *OH formation by the Fenton reaction. 61
10076064 1999
45
CD66c antigen expression is myeloid restricted in normal bone marrow but is a common feature of CD10+ early-B-cell malignancies. 61
9714468 1998
46
Transfusion-associated iron overload. 61
9359002 1997
47
Myelodysplasia and the leukemias. 61
9301644 1997
48
Molecular analysis of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 and p19 in the myelodysplastic syndromes. 61
9111168 1997
49
Iron chelation therapy. 61
9371986 1995
50
Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients. 61
7813708 1994
51
Transient erythroblastopenia of childhood in infants < 6 months of age. 61
8037344 1994
52
Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromes. 61
8167562 1994
53
Analysis of immunohistochemical results of the ras oncogene product p21 in myelodysplastic syndromes. 61
8352532 1993
54
[Myelodysplastic syndromes or refractory anemias]. 61
8235387 1993
55
[Clinical application of retinoic acid and vitamin D3 derivatives to the treatment of refractory anemias]. 61
8387118 1993
56
Common blood disorders: a primary care approach. 61
8462884 1993
57
Seronegative inflammatory arthritis in the myelodysplastic syndromes. 61
1626280 1992
58
Pathologic sideroblastosis in myelodysplastic syndromes and acute nonlymphocytic leukemia. 61
1763231 1991
59
Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics. 61
1859889 1991
60
[Myelodysplastic syndromes and refractory anemias with reference to the erythropoietic abnormalities]. 61
2041184 1991
61
Recombinant human GM-CSF: present clinical results and potential use in oncologic and hematologic disorders. 61
1786428 1991
62
Long-term (5 to 20 years) Evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias. 61
2257296 1990
63
Erythroid cultures and erythropoietin assay. Clinical and diagnostic value. 61
2112239 1990
64
Prognosis of refractory anemias. 61
2629462 1989
65
Chronic pure thrombocytopenia in elderly patients. An aspect of the myelodysplastic syndrome. 61
2819658 1989
66
Prognostic factors in refractory anemias. 61
3247816 1988
67
Thymoma and aregenerative anemia. 61
3420452 1988
68
[Prednisolone, 1 alpha hydroxyvitamin D3 and androgens in the management in patients with refractory anemias]. 61
2837980 1988
69
[The so-called refractory anemias]. 61
3116665 1987
70
Diagnosis and management of red cell aplasia in children. 61
3129394 1987
71
Erythropoietin titers in response to anemia or hypoxia. 61
3663951 1987
72
Refractory anemia in the elderly. 61
3548248 1987
73
[Bone marrow biopsy in the study of acquired refractory anemias]. 61
3784658 1986
74
[Refractory anemias in Japan]. 61
3806983 1986
75
Factors influencing leukemic transformation in refractory anemias with excess of blasts, with ringed sideroblasts, and without ringed sideroblasts. 61
3458528 1986
76
Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias. 61
2872720 1986
77
A variant myelodysplastic syndrome with multilineage Pelgeroid chromatin. 61
3946301 1986
78
[Transmission ultrastructure in the study of acquired refractory anemias]. 61
3458311 1986
79
[Proposals of the diagnostic criteria for refractory anemias]. 61
3712780 1986
80
Refractory anemias, pre-leukemia and myelodysplasias. 61
3836481 1985
81
Toxic etiology of aplastic anemia. The Cooperative Study Group for Aplastic and Refractory Anemias. 61
6523314 1984
82
[Refractory anemias. Clinico-hematological study of 16 patients]. 61
6377412 1984
83
[Application of in vitro culture of granulocyte-monocyte colony-forming stem cells (CFC-GM) from bone marrow in the study of refractory anemias]. 61
6484777 1984
84
[Incidence of neoplasms in non-congenital refractory anemias. Ferrokinetic pattern]. 61
6546177 1984
85
Does treatment with ARA-C in low dosage cause differentiation of leukemic cells? 61
6860796 1983
86
Erythroid burst formation in cultures of bone marrow and peripheral blood from patients with refractory anemia. 61
6408862 1983
87
The bone marrow in systemic podophyllin toxicity. 61
7072657 1982
88
Does the monthly frequency of medullary aplasia vary throughout the year? An analysis of the Cooperative Group Study of Aplastic and Refractory Anemias. 61
6812361 1982
89
[Protein composition of the erythrocyte membrane in refractory anemias]. 61
7330333 1981
90
Long-term follow-up in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Joint Group for the Study of Aplastic and Refractory Anemias. 61
7282742 1981
91
Serum ferritin in refractory anemias. 61
6794292 1981
92
Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anemias. 61
389402 1979
93
Present results of the cooperative studies on aplastic and refractory anemias. 61
115204 1979
94
Treatment of refractory anemias with methenolone. 61
367090 1979
95
Megaloblastic anemia. 61
704501 1978
96
[Enzyme deficiencies of blood cells in bone marrow insufficiency (author's transl]. 61
148542 1978
97
Acute megakaryocytic leukemia. Description of a case initially seen as preleukemia syndrome. 61
565623 1978
98
Red-cell hypoplasia and increased bone marrow reticulin in systemic lupus erythematosus: reversal with corticosteroid therapy. 61
752263 1978
99
[Effect of altitude hypoxia on the erythropoiesis of animals with experimental aregenerative anemia]. 61
22184 1977
100
[Chronic extemporal aregenerative anemia as a possible transition form between primary global bone-marrow aplasia and chronic idiopathic erythroblastopenia not associated with thymoma. Clinical contribution]. 61
854221 1977
101
[Refractory anemias--classification and treatment]. 61
979416 1976
102
Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases. 61
134855 1976
103
[Refractory anemias with partial myeloblastosis. Analysis of a protocol comprising 79 cases. 1. Clinical characteristics and evolution under androgen therapy]. 61
1065863 1976
104
Specificity of the 5q-chromosome in a distinct type of refractory anemia. 61
994197 1976
105
Rapid detection of ringed sideroblasts in erythremic myelosis. 61
46752 1975
106
[Idiopathic acquired dysplastic anemia developped under the picture of global hematopoietic insufficiency. Contribution to the study of so-called refractory anemias]. 61
1223724 1975
107
Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia. 61
238679 1975
108
Alterations in erythropoiesis preceding leukemia. 61
809958 1975
109
[Letter: sideroblastic refractory anemias after local cobalt therapy]. 61
4531646 1974
110
[Course of refractory anemias. Study of 49 cases]. 61
4532471 1974
111
[Evolution of refractory anemias. Relations with myelo-monocytic leukemias]. 61
4531254 1974
112
The effectiveness of splenectomy in the treatment of aregenerative anemia. Aplastic and hypoplastic anemia. 61
4807706 1973
113
[Refractory anemias: leukemic conditions (evolution of 16 cases)]. 61
4270589 1973
114
[Glass adhesiveness and phagocytic activity of neutrophil leukocytes in myeloproliferative syndromes and refractory anemias]. 61
4574489 1973
115
[Study of refractory anemias with radioactive isotopes]. 61
4727210 1973
116
[Refractory anemias and chromosome abnormalities. A new approach of preleukemic conditions]. 61
4506247 1972
117
[Sideroblastic refractory anemias (apropos of 3 cases)]. 61
5291000 1971
118
[Erythrocyte metabolism in acquired hemolytic and refractory anemias]. 61
4145003 1971
119
Refractory anemias, 1969. The Tinsley Harrison lecture, September 28, 1969. 61
5428556 1970
120
[Aregenerative anemia in the course of a so-called benign thymus tumor]. 61
4186489 1969
121
[Changes in the content of adenosine triphosphate, adenosine, 2,3-diphosphoglycerate and of anorganic phosphate in erythrocytes in hemolytic conditions and refractory anemias]. 61
5786015 1969
122
[Erythrocyte enzymatic activity in refractory anemias]. 61
4237805 1969
123
[Electron microscopic study of 11 cases of refractory anemias with multiple enzymopathies]. 61
4237815 1969
124
The composition of red cell lipids and the activity of two enzymes of the erythrocyte membrane (ATPase and acetylcholinesterase) in primary refractory anemias. 61
4236182 1969
125
[Refractory anemias: acquired enzymopathies of hematopoietic stem cells]. 61
4237814 1969
126
[The refractory anemias: multiple acquired enzymopathies of the hematopoietic stem cell]. 61
4236861 1968
127
[Erythrokinetics in hypoplastic pancytopenias, panmyelopathies and sideroblastic refractory anemias]. 61
5662873 1968
128
Red cell carbohydrate metabolism in primary refractory anemias. 61
6064691 1967
129
Refractory anemia with hyperplastic bone marrow (aregenerative anemia). 61
4864460 1967
130
Refractory anemias. 61
4859724 1967
131
[The so-called refractory anemias]. 61
4877150 1967
132
[On the defensive tissues in idiopathic aregenerative anemia]. 61
6070234 1967
133
[On the current problems of primary refractory anemias]. 61
5976802 1966
134
[Glucose-6-phosphate dehydrogenase activity in hemolytic and refractory anemias]. 61
5930082 1966
135
[Cytodynamic models of the erythron in different refractory anemias of basically hypoformative mechanism. II. Some aspects of erythroblastic-erythrocytic movement across the erythron compartments]. 61
5909177 1966
136
[Cytodynamic models of the erythron in different refractory anemias of basically hypoformative mechanism. I. General patterns of erythropoiesis]. 61
5909176 1966
137
[AREGENERATIVE ANEMIA IN THE NEWBORN]. 61
14205141 1964
138
[PRENEOPLASTIC SIDEROBLASTIC REFRACTORY ANEMIAS]. 61
14188999 1964
139
THE SYNDROME OF BENIGN THYMOMA AND PRIMARY AREGENERATIVE ANEMIA; AN ANALYSIS OF FORTY-THREE CASES. 61
14169820 1964
140
[PRENEOPLASTIC, SIDEROBLASTIC REFRACTORY ANEMIAS]. 61
14135962 1964
141
Refractory anemias with siderosis. 61
14014308 1963
142
[Hypersideremic hypochromic anemias (sideoachrestic or normoblastic refractory anemias)]. 61
14025732 1963
143
Refractory aregenerative anemia and benign thymoma treated by thymectomy with remission. 61
14023694 1963
144
Anemias in childhood resulting from bone-marrow deficiencies. Nutritional, aplastic and refractory anemias. 61
13898966 1962
145
Use of nandrolone phenpropionate in refractory anemias. 61
14470556 1961
146
[Biochemistry and clinical aspects of the effect of cobalt on iron-refractory anemias]. 61
13717791 1961
147
Refractory anemias of pregnancy. 61
13715422 1960
148
Elective thymectomy in the treatment of aregenerative anemia associated with monocytic leukemia. 61
13833083 1960
149
[Aregenerative anemia of the newborn (Kaznelson-Baar type)]. 61
14418309 1959
150
Aregenerative anemia associated with benign thymoma. 61
13566459 1958
151
Cobaltous chloride in the treatment of certain refractory anemias. 61
13248860 1955
152
Splenectomy for pure red-cell hypoplastic (aregenerative) anemia associated with autoimmune hemolytic disease; report of a case. 61
13214388 1954
153
[Cobalt therapy of iron refractory anemias after surgery of the stomach]. 61
14923482 1952
154
[Primary refractory anemias in children]. 61
14863983 1951
155
Chronic congenital aregenerative anemia (pure red-cell anemia) associated with iso-immunization by the blood. 61
18129754 1949
156
About congenital aregenerative anemia. 61
18105618 1948

Variations for Aregenerative Anemia

Expression for Aregenerative Anemia

Search GEO for disease gene expression data for Aregenerative Anemia.

Pathways for Aregenerative Anemia

GO Terms for Aregenerative Anemia

Sources for Aregenerative Anemia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....